Carregant...
Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
Fremanezumab is a fully humanized monoclonal antibody (IgG2Δa) that targets calcitonin gene-related peptide (CGRP), a key neuropeptide involved in the pathophysiology of migraine. Fremanezumab is approved for quarterly and monthly subcutaneous dosing for the preventive treatment of migraine in adult...
Guardat en:
| Publicat a: | Emerg Top Life Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Portland Press Ltd.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487173/ https://ncbi.nlm.nih.gov/pubmed/32832978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/ETLS20200018 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|